<DOC>
	<DOC>NCT01463943</DOC>
	<brief_summary>The study's objective is to evaluate the efficacy and safety of two formulations for the prophylactic treatment of diarrhea in subjects using antibiotics.</brief_summary>
	<brief_title>Non-Inferiority Trial Comparing Eurofarma's Experimental Product Saccharomyces Boulardii Versus FloratilÂ® in the Prevention of Antibiotic-Associated Diarrhea</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<criteria>1. ICF signature; 2. The subject must agree to follow the instructions and to perform study procedures and visits; 3. Male and female subjects between 18 and 65 years old; 4. Subjects who have scheduled a treatment or started the use of antibiotics over 24 hours ago: 1. Generalized infection or bacteremia; 2. Chronic gastrointestinal diseases (e.g., Crohn's Disease and Irritable Bowel Syndrome); 3. Documented chronic diarrhea; 4. Acute diarrhea episode within 24 hours prior to the start of antibiotic use. Use of tube feeding (nasogastric and nasoenteral); 5. Immunodeficiency (radiotherapy or chemotherapy); 6. Use of food with probiotic properties in the last 10 days;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>